Skip to main content

Safe Harbor Financial Reports First Quarter 2026 Results and Provides Corporate Update

First Quarter 2026 Revenue of Approximately $2.0 Million, Up 2.2% Year Over Year Loan Program Income Up 55.6% Year Over Year to Approximately $0.8 Million Total Operating Expenses Down 4.7% Year Over Year Cash and Cash Equivalents of $5.9 Million and Stockholders’ Equity of $6.7 Million as of March 31, 2026 DENVER, May 18, 2026 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, today announced its financial results for the first quarter ended March 31, 2026. “Our first quarter results reflect meaningful progress across the core drivers of our business. Loan program income grew more than 55% year over year,...

Continue reading

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

Key highlights from the first quarter of operations under the expanded management team include the following:Anticipated FDA decision on the Company’s ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations already received from the FDA Office of Generic Drugs on bioequivalence, labeling, drug product, drug substance, and safety. Initiation of commercial manufacturing of Ketamine at the 1 million dose per month level with recent FDA inspection of the manufacturing facility and granting of inspection status consistent with launch of an ANDA drug. Completed a Type C meeting with the FDA Division of Psychiatry Products and CDER leadership, in which the Agency expressed openness to existing clinical trial data and Real World Evidence supporting approval without additional trials. Presidential Executive...

Continue reading

Brady Corporation Reports Record Adjusted EPS in its Fiscal 2026 Third Quarter and Raises its Fiscal 2026 Adjusted EPS Guidance

Sales for the quarter increased 13.8 percent compared to the same quarter of the prior year. Organic sales increased 8.2 percent, acquisitions increased sales 2.1 percent and foreign currency translation increased sales 3.5 percent. Diluted EPS increased 11.0 percent to $1.21 in the third quarter of fiscal 2026 compared to $1.09 in the same quarter of the prior year. Adjusted Diluted EPS* increased 23.0 percent to $1.50 in the third quarter of fiscal 2026 compared to $1.22 in the same quarter of the prior year. Net cash provided by operating activities increased to $78.2 million in the third quarter of fiscal 2026 compared to $59.9 million in the third quarter of last year. GAAP earnings per diluted Class A Nonvoting Common share guidance for the year ending July 31, 2026 was adjusted from the previous range of $4.62 to $4.82 per share...

Continue reading

Onfolio Holdings Inc. Announces Q1 2026 Financial Results and Provides Corporate Update

Conference Call to Discuss Q1 2026 Results Scheduled for Today at 8:00 a.m. ET WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (“Onfolio” or the “Company”), an owner-operator of cash-generative online businesses, announces financial results for the first quarter ended March 31, 2026. Recent Corporate HighlightsActivated acquisition program and will target the acquisition of between $5 million and $10 million in aggregate annual adjusted EBITDA before the end of 2026. Secured a $100 million equity financing facility in April 2026 to accelerate acquisition strategy. Regained compliance with Nasdaq Listing Rule 5550(a)(2) as of May 1, 2026.First Quarter 2026 Financial HighlightsRevenue was $1.87M vs. $2.81M in Q1 2025 Gross profit decreased 46% to $0.92M, or 49% of...

Continue reading

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Completed successful FDA End-of-Phase 2 meeting, reaching alignment on the study parameters of RESTORE, a registrational study of NVG-291 in chronic tetraplegia, with site activation underway and study initiation on track for mid-2026.  Independent, blinded biomechanical gait analyses of the CONNECT SCI study designed to differentiate genuine neural recovery from compensatory movement remain ongoing, with results anticipated in 2Q 2026. Successfully listed on Nasdaq under the symbol ‘NGEN’ on January 8, 2026, and voluntarily delisted from the TSX Venture Exchange. Strengthened leadership team with three senior appointments to support late-stage clinical development and Nasdaq listing.VANCOUVER, British Columbia, May 18, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (NASDAQ: NGEN),...

Continue reading

iQIYI Announces First Quarter 2026 Financial Results

BEIJING, May 18, 2026 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsTotal revenues were RMB6.23 billion (US$902.5 million1), decreasing 13% year over year. Operating loss was RMB228.4 million (US$33.1 million) and operating loss margin was 4%, compared to operating income of RMB341.9 million and operating income margin of 5% in the same period in 2025. Non-GAAP operating loss2 was RMB148.6 million (US$21.5 million) and non-GAAP operating loss margin was 2%, compared to non-GAAP operating income of RMB458.5 million and non-GAAP operating income margin of 6% in the same period in 2025. Net loss attributable to iQIYI...

Continue reading

Niu Technologies Announces Unaudited First Quarter 2026 Financial Results

— First Quarter Revenues of RMB 909.5 million, up 33.4% year over year — First Quarter Net Loss of RMB 93.9 million, compared with RMB 38.8 million in the same period of 2025 BEIJING, May 18, 2026 (GLOBE NEWSWIRE) — Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial HighlightsRevenues were RMB 909.5 million, an increase of 33.4% year over year Gross margin was 17.4%, compared with 17.3% in the first quarter of 2025 Net loss was RMB 93.9 million, compared with RMB 38.8 million in the first quarter of 2025 Adjusted net loss (non-GAAP)1 was RMB 88.0 million, compared with RMB 31.4 million in the first quarter of 2025First Quarter...

Continue reading

BW Offshore: First quarter results 2026

First quarter results 2026 HIGHLIGHTSQ1 EBITDA of USD 47.9 million and operating cash flow of USD 43.3 million Robust balance sheet with USD 568 million in available liquidity Q1 cash dividend of USD 0.063 per share BW Opal production restarted, commissioning and practical completion expected mid-2026 Signed FEED with Equinor for Bay du Nord FPSO and established local office in St. John’s Extended BW Catcher contract through 2030 Strategic review progressing Full-year 2026 EBITDA guidance revised to USD 310-340 millionOn BW Opal, the replacement of the compressor dry-gas seals was completed in March. Gas production recommenced in early May after a temporary shutdown during March and April for cleaning the heat exchanger trains. A root cause analysis of the heat exchanger fouling has been completed and is currently under joint review...

Continue reading

LiveRamp Announces Fourth Quarter and Fiscal Year 2026 Results

Q4 Revenue up 9% year-over-yearQ4 Annual Recurring Revenue up 8% year-over-yearQ4 Subscription Net Retention improved to 107%FY26 record annual Operating Cash Flow of $168 million and Share Repurchases of $194 million LiveRamp Enters into Definitive Agreement to be Acquired by Publicis Groupe in All-Cash Transaction with an Equity Value of $2.5 billion SAN FRANCISCO, May 17, 2026 (GLOBE NEWSWIRE) — LiveRamp® (NYSE: RAMP), a leading data collaboration platform, today announced its financial results for the quarter and fiscal year ended March 31, 2026. Q4 Financial HighlightsUnless otherwise indicated, all comparisons are to the prior year period.Total revenue was $206 million, up 9%.Subscription revenue was $158 million, up 9%.Marketplace & Other revenue was $49 million, up 11%.GAAP gross profit was $146 million, up...

Continue reading

SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026

CALGARY, AB, May 17, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV:SEGN) (“Seegnal” or the “Company”) announces that the management cease trade order (the “MCTO”), issued by the Alberta Securities Commission on May 8, 2026, at the request of the Company, will no longer be in effect as of May 16, 2026. On May 13, 2026, the Company filed its audited consolidated financial statements for the year ended December 31, 2025, together with the related management’s discussion and analysis and the Chief Executive Officer and the Chief Financial Officer certifications. The MCTO applied only to the Chief Executive Officer and the Chief Financial Officer and did not affect the ability of the general investing public to trade in the Company’s securities. The Company confirms that it is current with its continuous disclosure obligations and anticipates...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.